GlassScriptPhysician profile
Dudley S Danoff
NPI 1023042496
$3,643.53
in general payments reported to CMS, 2019-2025
31 companies · $793 in 2025
The $793 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $166 · 2021: $481 · 2022: $621 · 2023: $531 · 2024: $630 · 2025: $793.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,854 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,854.41 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $538.46 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $381.22 | 2019-2023 | Xtandi |
| Abbvie INC. | $347.90 | 2022-2025 | Botox |
| Becton, Dickinson and Company | $339.65 | 2024 | Bard Urinary Drainage Bag |
| Pfizer INC. | $233.56 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $231.49 | 2021-2023 | |
| Teleflex LLC | $212.73 | 2021-2025 | Urolift |
| Rochester Medical Corporation | $152.25 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $128.77 | 2023-2024 | Bard Urinary Drainage Bag |
| Telix Pharmaceuticals | $118.36 | 2024-2025 | Illuccix |
| Dornier Medtech America, INC | $102.06 | 2025 | Dornier Medtech |
| Myovant Sciences INC. | $101.62 | 2021-2022 | |
| Blue Earth Diagnostics | $91.72 | 2022-2025 | Posluma |
| Profound Medical Corp. | $88.19 | 2023 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $83.26 | 2019-2025 | Adstiladrin |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $62.75 | 2023-2025 | Orgovyx |
| Allergan, INC. | $49.52 | 2021 | |
| Amgen INC. | $49.40 | 2019 | |
| Laborie Medical Technologies Corp. | $43.06 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $36.52 | 2025 | |
| Dendreon Pharmaceuticals LLC | $34.02 | 2019 | |
| Boston Scientific Corporation | $32.05 | 2019-2021 | |
| Abc Home Medical Supply, INC. | $23.76 | 2025 | |
| Immunitybio, INC. | $23.14 | 2025 | |
| Axonics, INC. | $22.39 | 2022 | |
| Karl Storz Endoscopy-America | $22.33 | 2019 | |
| Merck Sharp & Dohme LLC | $22.28 | 2024 | Lynparza |
| Astrazeneca Pharmaceuticals LP | $19.54 | 2021 | |
| Progenics Pharmaceuticals, INC. | $18.88 | 2022 | |
| Antares Pharma, INC. | $18.15 | 2022 | |
| Myriad Genetic Laboratories, INC. | $14.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dudley Danoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.